Medicure (MCUJF) Cash from Financing Activities (2011 - 2026)
Medicure (MCUJF) posted quarterly Cash from Financing Activities of -$81671.0 for Q1 2026, down 31.67% year-over-year from -$119530.0 in Q1 2025, and down 2.61% quarter-over-quarter from -$79596.6 in Q4 2025.
Medicure (MCUJF) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Medicure's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$81671.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 31.67% year-over-year to -$81671.0; the TTM figure through Mar 2026 stood at -$316937.9 (down 15.12% YoY), while the FY2025 annual figure was -$297024.4, down 9.91% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$81671.0, down from -$79596.6 in the prior quarter.
- The five-year high for Cash from Financing Activities was -$52886.6 in Q4 2023, with the low at -$167917.4 in Q3 2022.
- The 5-year median for Cash from Financing Activities is -$64085.6 (2022), against an average of -$76192.0.
- Peak annual rise in Cash from Financing Activities reached 81.68% in 2022, while the deepest fall reached 123.45% in 2022.
- Medicure's Cash from Financing Activities stood at -$167917.4 in 2022, then soared by 68.5% to -$52886.6 in 2023, then sank by 62.43% to -$85901.9 in 2024, then advanced by 7.34% to -$79596.6 in 2025, then declined by 2.61% to -$81671.0 in 2026.
- Business Quant data shows MCUJF's Cash from Financing Activities at -$81671.0 in Q1 2026, -$79596.6 in Q4 2025, and -$74116.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | -81,671.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81,671.04 |
| Mar 31, 2026 | -81,671.04 |
| Dec 31, 2025 | -79,596.58 |
| Dec 31, 2025 | -79,596.58 |
| Sep 30, 2025 | -74,116.77 |
| Sep 30, 2025 | -74,116.77 |
| Jun 30, 2025 | -81,553.51 |
| Jun 30, 2025 | -81,553.51 |
| Mar 31, 2025 | -62,025.57 |
| Mar 31, 2025 | -62,025.57 |
| Dec 31, 2024 | -85,901.90 |
| Dec 31, 2024 | -85,901.90 |
| Sep 30, 2024 | -61,576.49 |
| Sep 30, 2024 | -61,576.49 |
| Jun 30, 2024 | -65,802.65 |
| Jun 30, 2024 | -65,802.65 |
| Mar 31, 2024 | -56,400.60 |
| Mar 31, 2024 | -56,400.60 |
| Dec 31, 2023 | -52,886.56 |
| Dec 31, 2023 | -52,886.56 |